311 related articles for article (PubMed ID: 14996857)
1. Lifetime risks of common cancers among retinoblastoma survivors.
Fletcher O; Easton D; Anderson K; Gilham C; Jay M; Peto J
J Natl Cancer Inst; 2004 Mar; 96(5):357-63. PubMed ID: 14996857
[TBL] [Abstract][Full Text] [Related]
2. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
3. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma.
Kleinerman RA; Tucker MA; Abramson DH; Seddon JM; Tarone RE; Fraumeni JF
J Natl Cancer Inst; 2007 Jan; 99(1):24-31. PubMed ID: 17202110
[TBL] [Abstract][Full Text] [Related]
4. Bone and Soft-Tissue Sarcoma Risk in Long-Term Survivors of Hereditary Retinoblastoma Treated With Radiation.
Kleinerman RA; Schonfeld SJ; Sigel BS; Wong-Siegel JR; Gilbert ES; Abramson DH; Seddon JM; Tucker MA; Morton LM
J Clin Oncol; 2019 Dec; 37(35):3436-3445. PubMed ID: 31622129
[TBL] [Abstract][Full Text] [Related]
5. Cause-specific mortality in long-term survivors of retinoblastoma.
Yu CL; Tucker MA; Abramson DH; Furukawa K; Seddon JM; Stovall M; Fraumeni JF; Kleinerman RA
J Natl Cancer Inst; 2009 Apr; 101(8):581-91. PubMed ID: 19351917
[TBL] [Abstract][Full Text] [Related]
6. Mortality from second tumour among long-term survivors of retinoblastoma: a retrospective analysis of the Italian retinoblastoma registry.
Acquaviva A; Ciccolallo L; Rondelli R; Balistreri A; Ancarola R; Cozza R; Hadjistilianou D; Francesco SD; Toti P; Pastore G; Haupt R; Carli M; Santoro N; Di Cataldo A; Fiorillo A; Indolfi P; Nucci P; Sandri A; Porta F; Porcaro AB; Tamaro P; Morgese G
Oncogene; 2006 Aug; 25(38):5350-7. PubMed ID: 16936757
[TBL] [Abstract][Full Text] [Related]
7. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up.
Kleinerman RA; Tucker MA; Tarone RE; Abramson DH; Seddon JM; Stovall M; Li FP; Fraumeni JF
J Clin Oncol; 2005 Apr; 23(10):2272-9. PubMed ID: 15800318
[TBL] [Abstract][Full Text] [Related]
8. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
Travis LB; Fosså SD; Schonfeld SJ; McMaster ML; Lynch CF; Storm H; Hall P; Holowaty E; Andersen A; Pukkala E; Andersson M; Kaijser M; Gospodarowicz M; Joensuu T; Cohen RJ; Boice JD; Dores GM; Gilbert ES
J Natl Cancer Inst; 2005 Sep; 97(18):1354-65. PubMed ID: 16174857
[TBL] [Abstract][Full Text] [Related]
9. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk.
Wong FL; Boice JD; Abramson DH; Tarone RE; Kleinerman RA; Stovall M; Goldman MB; Seddon JM; Tarbell N; Fraumeni JF; Li FP
JAMA; 1997 Oct; 278(15):1262-7. PubMed ID: 9333268
[TBL] [Abstract][Full Text] [Related]
10. For whom the bell tolls: susceptibility to common adult cancers in retinoblastoma survivors.
Kaye FJ; Harbour JW
J Natl Cancer Inst; 2004 Mar; 96(5):342-3. PubMed ID: 14996847
[No Abstract] [Full Text] [Related]
11. Retinoblastoma in Infancy with Subsequent Bladder Leiomyosarcoma in Adulthood: Genomic Considerations.
Ohan H; Minassian G; Minassian H; Farooq T; Zdilla MJ
Urology; 2020 Jun; 140():38-40. PubMed ID: 32197986
[TBL] [Abstract][Full Text] [Related]
12. Correlation between RB1germline mutations and second primary malignancies in hereditary retinoblastoma patients treated with external beam radiotherapy.
Chaussade A; Millot G; Wells C; Brisse H; Laé M; Savignoni A; Desjardins L; Dendale R; Doz F; Aerts I; Jimenez I; Cassoux N; Stoppa Lyonnet D; Gauthier Villars M; Houdayer C
Eur J Med Genet; 2019 Mar; 62(3):217-223. PubMed ID: 30031154
[TBL] [Abstract][Full Text] [Related]
13. Variation of second cancer risk by family history of retinoblastoma among long-term survivors.
Kleinerman RA; Yu CL; Little MP; Li Y; Abramson D; Seddon J; Tucker MA
J Clin Oncol; 2012 Mar; 30(9):950-7. PubMed ID: 22355046
[TBL] [Abstract][Full Text] [Related]
14. Retinoblastoma survivors: sarcomas and surveillance.
Meadows AT
J Natl Cancer Inst; 2007 Jan; 99(1):3-5. PubMed ID: 17202103
[No Abstract] [Full Text] [Related]
15. Risk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapy.
Wong JR; Morton LM; Tucker MA; Abramson DH; Seddon JM; Sampson JN; Kleinerman RA
J Clin Oncol; 2014 Oct; 32(29):3284-90. PubMed ID: 25185089
[TBL] [Abstract][Full Text] [Related]
16. Mortality from second tumors among long-term survivors of retinoblastoma.
Eng C; Li FP; Abramson DH; Ellsworth RM; Wong FL; Goldman MB; Seddon J; Tarbell N; Boice JD
J Natl Cancer Inst; 1993 Jul; 85(14):1121-8. PubMed ID: 8320741
[TBL] [Abstract][Full Text] [Related]
17. RB1 mutations and second primary malignancies after hereditary retinoblastoma.
Dommering CJ; Marees T; van der Hout AH; Imhof SM; Meijers-Heijboer H; Ringens PJ; van Leeuwen FE; Moll AC
Fam Cancer; 2012 Jun; 11(2):225-33. PubMed ID: 22205104
[TBL] [Abstract][Full Text] [Related]
18. Cancer mortality in long-term survivors of retinoblastoma.
Marees T; van Leeuwen FE; de Boer MR; Imhof SM; Ringens PJ; Moll AC
Eur J Cancer; 2009 Dec; 45(18):3245-53. PubMed ID: 19493675
[TBL] [Abstract][Full Text] [Related]
19. Long-term risk of subsequent cancer incidence among hereditary and nonhereditary retinoblastoma survivors.
Schonfeld SJ; Kleinerman RA; Abramson DH; Seddon JM; Tucker MA; Morton LM
Br J Cancer; 2021 Mar; 124(7):1312-1319. PubMed ID: 33473166
[TBL] [Abstract][Full Text] [Related]
20. Incidence of second cancers after radiotherapy and systemic chemotherapy in heritable retinoblastoma survivors: A report from the German reference center.
Temming P; Arendt M; Viehmann A; Eisele L; Le Guin CH; Schündeln MM; Biewald E; Astrahantseff K; Wieland R; Bornfeld N; Sauerwein W; Eggert A; Jöckel KH; Lohmann DR
Pediatr Blood Cancer; 2017 Jan; 64(1):71-80. PubMed ID: 27567086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
